About Nexien BioPharma
Nexien BioPharma is a company based in Denver (United States) founded in 1952 by Richard S Greenberg. It operates as a Professional Services, Licensing Model, and HealthTech. Nexien BioPharma has completed 1 acquisition, including CRX Bio. Nexien BioPharma offers products and services including Cannabinoid Medications, Delivery Systems, and Investment in Cannabinoid Research. Nexien BioPharma operates in a competitive market with competitors including MediPharm Labs, Holistic Industries, Motif Labs, Vertosa and FarmaceuticalRX, among others.
- Headquarter Denver, United States
- Founders Richard S Greenberg
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nexien Biopharma Inc
-
Annual Revenue
Not available
-
Net Profit
-$239.11 K (USD)33.93as on Jun 30, 2024
-
EBITDA
-$155.66 K (USD)44.92as on Jun 30, 2024
-
Latest Funding Round
$1.4 M (USD), Post-IPO
Nov 29, 2017
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nexien BioPharma
Nexien BioPharma offers a comprehensive portfolio of products and services, including Cannabinoid Medications, Delivery Systems, and Investment in Cannabinoid Research.
Cannabinoid-based drugs are developed for medical conditions.
Proprietary systems are created for cannabinoid medication delivery.
Investments are made in cannabinoid research technologies.
People of Nexien BioPharma
Unlock access to complete
Funding Insights of Nexien BioPharma
Investments & Acquisitions by Nexien BioPharma
Nexien BioPharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CRX Bio.
Investment portfolio details for Nexien BioPharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cannabis research and development services are provided to clients.
|
Locked | Locked | 2017 | Locked |
Complete acquisition details for Nexien BioPharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Nexien BioPharma
Detailed financials for Nexien BioPharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nexien Biopharma Comparisons
Peer comparison for Nexien BioPharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nexien BioPharma
Nexien BioPharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MediPharm Labs, Holistic Industries, Motif Labs, Vertosa and FarmaceuticalRX, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical-grade cannabinoid products and APIs are manufactured.
|
|
| Locked | Locked | Locked |
Proprietary medical cannabis strains are developed and offered.
|
|
| Locked | Locked | Locked |
Cannabinoid extraction, purification, and formulation services are provided.
|
|
| Locked | Locked | Locked |
Technology for active ingredients from infused hemp is provided.
|
|
| Locked | Locked | Locked |
Cannabis-based products including flower and concentrates are manufactured and supplied.
|
|
| Locked | Locked | Locked |
Oral cannabis-based healthcare products are developed for therapeutic treatments.
|
Detailed competitors of Nexien BioPharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nexien Biopharma
Complete news archive for Nexien BioPharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nexien BioPharma
Nexien BioPharma was founded in 1952 and raised its 1st funding round 65 years after it was founded.
Nexien BioPharma is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.
Richard S Greenberg is the current CEO of Nexien BioPharma. They have also founded this company.
Nexien BioPharma is focused on the research and development of cannabinoid-based pharmaceuticals in compliance with United States Food and Drug Administration (FDA) regulatory pathways. Operations are conducted with DEA-licensed clinical research organizations, contract manufacturing partners, and academic institutions. The company pursues three synergistic paths: developing and licensing cannabinoid medications for specific medical conditions, creating proprietary delivery systems for accurate dosing, and investing in cannabinoid research technologies through special purpose vehicles. Activities are centered in the healthcare sector with an emphasis on innovative drug solutions.
Nexien BioPharma's top competitors include Holistic Industries, MediPharm Labs and FarmaceuticalRX.
Nexien BioPharma offers Cannabinoid Medications, Delivery Systems, and Investment in Cannabinoid Research.
Nexien BioPharma has made 1 acquisition, including CRX Bio.